Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P97
Near historical high
vs 2Y Ago
1.2x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 79.76% |
| Q2 2025 | -170.56% |
| Q1 2025 | 41.31% |
| Q4 2024 | 65.39% |
| Q3 2024 | -3.28% |
| Q2 2024 | -143.26% |
| Q1 2024 | 565.76% |
| Q4 2023 | -47.62% |
| Q3 2023 | 66.15% |
| Q2 2023 | 8.86% |
| Q1 2023 | 22.33% |
| Q4 2022 | -2.06% |
| Q3 2022 | -51.82% |
| Q2 2022 | -34.41% |
| Q1 2022 | 15.20% |
| Q4 2021 | -6.15% |
| Q3 2021 | -4.78% |
| Q2 2021 | 16.80% |
| Q1 2021 | -47.26% |
| Q4 2020 | 47.65% |
| Q3 2020 | -25.50% |
| Q2 2020 | -36.31% |
| Q1 2020 | 1.61% |
| Q4 2019 | -103.14% |
| Q3 2019 | 61.75% |
| Q2 2019 | -80.12% |
| Q1 2019 | 12.00% |
| Q4 2018 | -8.55% |
| Q3 2018 | -6.26% |
| Q2 2018 | -64.99% |
| Q1 2018 | 31.53% |
| Q4 2017 | 2.64% |
| Q3 2017 | -47.18% |
| Q2 2017 | -98.26% |
| Q1 2017 | 29.48% |
| Q4 2016 | -127.69% |
| Q3 2016 | 30.66% |
| Q2 2016 | -72.38% |
| Q1 2016 | 22.22% |
| Q4 2015 | -339.02% |